LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹581 Cr | ₹510 Cr | ₹472 Cr | ₹424 Cr | ₹386 Cr |
What is the latest Revenue of LINCOLN PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹581 Cr |
| Mar2024 | ₹510 Cr |
| Mar2023 | ₹472 Cr |
| Mar2022 | ₹424 Cr |
| Mar2021 | ₹386 Cr |
How is Revenue of LINCOLN PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹581 Cr | 13.76 | |
| Mar2024 | ₹510 Cr | 8.09 | |
| Mar2023 | ₹472 Cr | 11.30 | |
| Mar2022 | ₹424 Cr | 9.75 | |
| Mar2021 | ₹386 Cr | - | |
Compare Revenue of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,191.6 Cr | 1.1% | -3.5% | 13.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,530.0 Cr | -0.4% | 0.9% | 19.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹219,675.0 Cr | -1.2% | 21.1% | 29.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,970.0 Cr | -2.3% | 0.3% | 34.8% | Stock Analytics | |
| CIPLA | ₹117,947.0 Cr | 0.7% | 1.5% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,601.2 Cr | -0.3% | -7.1% | -3.9% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 1.1% |
-3.5% |
13.2% |
| SENSEX | -0.1% |
2.4% |
-3.3% |
You may also like the below Video Courses